Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Pfizer (NY:PFE)

27.05 -0.17 (-0.62%)
Official Closing Price Updated: 7:00 PM EST, Feb 9, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Pfizer

< Previous 1 2
...
17 18 19 20 21 22 23 24 25
...
39 40 Next >
News headline image
What Are Dividend Payment Dates?
What are dividend payment dates? The payment date is the day a company pays its eligible shareholders dividends. Learn more. 
Via MarketBeat
News headline image
U.S. FDA Accepts Biologics License Application for Pfizer’s Respiratory Syncytial Virus Maternal Vaccine Candidate for Priority Review
From Pfizer Inc.
Via Business Wire
News headline image
Bladder Prolapse (Cystocele) Market to Touch at High CAGR of 8.3% by 2022-2029
Bladder Prolapse (cystocele) Market is expected to grow at a CAGR of 8.3 % during the forecast period (2022-2029). 
Via SBWire
News headline image
Salivary Gland Cancer Treatment Market Outlook Growth Share Overview Analysis 2022-2029
Global Salivary Gland Cancer Treatment Market to Witness Huge Growth by Key Players: Bristol-Myers Squibb Company, LGM PHARMA, Pfizer Inc., Bedford Laboratories, Baxter, sanofi-aventis U.S. LLC, Pierre... 
Via SBWire
News headline image
Choroidal Neovascularization Market Share Size Trends Overview Analysis 2022-2029
Global Choroidal Neovascularization Market to Witness Huge Growth by Key Players: Bausch Health Companies Inc, Bayer AG, Gilead Sciences Inc, F.Hoffmann –La Roche AG,MaaT Pharma Novartis AG, Pfizer... 
Via SBWire
News headline image
Occupational Medicines Market Is Expected to Reach at High CAGR of 5.4% by 2022-2029
Occupational medicines market size was worth US$ XX million in 2021 and is estimated to reach US$ XX million by 2029, growing at a CAGR of 5.4 % during the forecast period (2022-2029). 
Via SBWire
News headline image
Zoetis, Pet-Med Specialist, Double-Digit Earnings Growth Ahead
Animal health company Zoetis is up 7.99% in the past week, after topping fourth-quarter views. Analysts see double-digit EPS growth in 2023 and 2024. 
Via MarketBeat
News headline image
Pfizer Announces Positive TALZENNA® and XTANDI® Combination Data from Phase 3 TALAPRO-2 Study
From Pfizer Inc.
Via Business Wire
News headline image
Pfizer Announces The Lancet Neurology Has Published Phase 3 Data for Zavegepant for the Acute Treatment of Migraine in Adults
From Pfizer Inc.
Via Business Wire
News headline image
Ziprasidone Market Trends Share Demand Overview Analysis 2022-2029
Global Ziprasidone Market to Witness Huge Growth by Key Players: Pfizer Inc., Sandoz AG, Lupin Pharmaceuticals, Inc., Mylan Pharmaceuticals, Apotex, Dr. Reddy's laboratories Ltd., Wockhardt, Aurobindo... 
Via SBWire
News headline image
Spinal Stenosis Treatment Market to Grow with a Growth Rate of 4% During 2022 to 2029
Spinal Stenosis Treatment Market size was valued USD million in 2021 and is estimated to reach USD million by 2029, growing at a CAGR of 4% during the forecast period (2022-2029). 
Via SBWire
News headline image
Undifferentiated Pleomorphic Sarcoma Therapeutics Market Share Volume Demand 2022 to 2029
The Undifferentiated Pleomorphic Sarcoma Therapeutics Market size was valued USD million in 2021 and is estimated to reach USD million by 2029, growing at a high CAGR during the forecast period... 
Via SBWire
News headline image
Water for Injection Market Trends Outlook Demand 2023 -2030
Global Water for Injection Market to Witness Huge Growth by Key Players: Abbott Laboratories, AdvaCare Pharma, B. Braun SE, FUJIFILM Holdings Corp., GlaxoSmithKline Plc, Merit Healthcare International... 
Via SBWire
News headline image
FDA Approves Pfizer's Supplemental New Drug Application for CIBINQO® (abrocitinib)
From Pfizer Inc.
Via Business Wire
News headline image
Gemcitabine HCL Market to Grow with a Growth Rate of 7% During 2023 to 2030
Gemcitabine HCL Market size is expected to reach at a CAGR of 7% during the forecast period (2023-2030). 
Via SBWire
BioRestorative Therapies Inc (NASDAQ: BRTX) Announces European Patentability Of ThermoStem® Program With Indications In Obesity And Type 2 Diabetes
By Julian Richard, Benzinga 
Via TheNewswire.com
Topics Intellectual Property
News headline image
Europe Liver Cancer Therapeutics Market to Reach at High CAGR of 8.95% by 2023-2030
The Europe liver cancer therapeutics size was valued at US$ 384 million in 2022 and is estimated to reach US$ 627 million by 2030, growing at a CAGR of 8.95% during the forecast period (2023-2030) 
Via SBWire
News headline image
Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference
From Pfizer Inc.
Via Business Wire
News headline image
Musculoskeletal Diseases Treatment Market Is Poised to Cross at High CAGR of 4.9% in 2023-2030
The Musculoskeletal Diseases Treatment Market size was valued at US$ YY million in 2023 and is estimated to reach US$ YY million by 2030, growing at a CAGR of 4.8% during the forecast period... 
Via SBWire
News headline image
Pain Relief Medication Market to Witness Huge Growth by Key Players: Pfizer Inc., Johnson & Johnson Services Inc., Bayer AG, Sanofi S.A., GlaxoSmithKline Plc.
Global Pain Relief Medication Market By Material (Acute, Chronic), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy) 
Via SBWire
News headline image
Active Pharmaceutical Ingredients Market May Set Epic Growth Story : Pfizer, Novartis, Sanofi
Stay up-to-date with Active Pharmaceutical Ingredients Market research offered by AMA Research. Check how key trends and emerging drivers are shaping this industry growth. 
Via SBWire
Topics Death
News headline image
Biosimilars Market 2023 Industry Size, Share, Growth and Analysis by Demand, Opportunity, Key Players, Regional Development and Forecast 2029
Biosimilars Market Size, Share and Forecast 2023-2029 Key Players are – Samsung Biologics, Intas Pharmaceuticals Ltd, Celltrion, Reliance Life Sciences, Pfizer, Coherus BioSciences, Amgen, Biocon Ltd 
Via SBWire
Topics Intellectual Property
News headline image
Cathie Woods' Ark Innovation ETF Set To Rebound in 2023?
Can gains in Tesla, Zoom, Exact Sciences, and other growth stocks set the stage for Cathie Woods' Ark Innovation Fund to stage a comeback in 2023? 
Via MarketBeat
Topics ETFs
News headline image
Novavax Shares Jumped in January While Others Slipped
Updated FDA Covid vaccine policy could've boosted NVAX shares at the end of January, when other pharma stocks slipped, but it may not affect the bottom line. 
Via MarketBeat
News headline image
Pfizer Stock: What the Bulls and Bears are Getting Wrong
Pfizer stock is bouncing up and down after mixed Q4 earnings. There's been an emotional battle between bulls and bears but it's time for both to get rational 
Via MarketBeat
News headline image
PFIZER REPORTS RECORD FULL-YEAR 2022 RESULTS AND PROVIDES FULL-YEAR 2023 FINANCIAL GUIDANCE
From Pfizer Inc.
Via Business Wire
News headline image
MarketBeat Week in Review – 1/23- 1/27
Markets were pushing hard to continue the rally as.recession fears and layoff announcements offset two data points that suggest inflation may be easing 
Via MarketBeat
Topics Economy Workforce
News headline image
How Could GSK's RSV Vaccine Change its Valuation?
GSK's RSV vaccine could be a good earner for the company, according to outside analysts and its own predictions for the future. 
Via MarketBeat
News headline image
Is the Pain Over for Baudax Bio Investors after a 70% Spike?
Baudax Bio (NASDAQ: BXRX) shares spiked as much as 70% on its announcement of positive interim phase 2 clinical trials for its pain medicine BX1000. 
Via MarketBeat
News headline image
A Comprehensive Study Exploring Balantidiasis Market : Key Players Fougera Pharmaceuticals, Medtronic, NuVasive
Get Balantidiasis Market analysis, key vendors & competitive scenario of the market prepared using market research tools such as Porter’s five forces and SWOT analysis. 
Via SBWire
< Previous 1 2
...
17 18 19 20 21 22 23 24 25
...
39 40 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.